GlobalDeal

Biofrontera Group

Pharmaceuticals · Leverkusen, Germany

biofrontera-us.com

About Biofrontera Group

Biofrontera Group is a biopharmaceutical company focused on the development and commercialization of innovative dermatological products. The company specializes in the treatment of skin cancer and other skin diseases, leveraging its proprietary technology to enhance the efficacy of its products. Biofrontera's flagship product, Ameluz, is used for the treatment of actinic keratosis and is marketed in various countries. The company is committed to advancing dermatological care through research and development, aiming to improve patient outcomes and quality of life. With a strong presence in Europe and expanding operations in the United States, Biofrontera is positioned as a leader in the dermatology sector.

Company facts

Industry
Pharmaceuticals
Sub-industries
Dermatology, Biopharmaceuticals, Oncology, Skin Care, Medical Devices
Location
Leverkusen, Germany
Employees
51–200
Founded
1997

Products and services

Open Biofrontera Group in GlobalDeal Is this your company? Update the details for free

More Pharmaceuticals companies in Germany

All 4,050 Pharmaceuticals companies in Germany →